- Home
- KPTI vs SNAL Comparison
KPTI vs SNAL Comparison
Compare KPTI & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPTI | SNAL |
|---|---|---|
| Founded | 2008 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.6M | 29.8M |
| IPO Year | 2013 | 2022 |
Fundamental Metrics
Financial Performance| Metric | KPTI | SNAL |
|---|---|---|
| Price | $7.59 | $0.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $17.50 | N/A |
| AVG Volume (30 Days) | ★ 603.2K | 20.1K |
| Earning Date | 02-12-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 120.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $146,067,000.00 | $81,225,622.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $46.62 | $50.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $3.51 | $0.56 |
| 52 Week High | $10.99 | $2.15 |
Technical Indicators
Market Signals| Indicator | KPTI | SNAL |
|---|---|---|
| Relative Strength Index (RSI) | 40.32 | 34.11 |
| Support Level | $7.15 | N/A |
| Resistance Level | $7.81 | $0.98 |
| Average True Range (ATR) | 0.79 | 0.05 |
| MACD | -0.21 | -0.00 |
| Stochastic Oscillator | 7.83 | 5.87 |
Price Performance
Historical ComparisonAbout KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
About SNAL Snail Inc.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.